Eric M Pridgen
Overview
Explore the profile of Eric M Pridgen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
787
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Xiao Z, Ji C, Shi J, Pridgen E, Frieder J, Wu J, et al.
Angew Chem Int Ed Engl
. 2012 Oct;
51(47):11853-7.
PMID: 23081716
No abstract available.
12.
Valencia P, Pridgen E, Perea B, Gadde S, Sweeney C, Kantoff P, et al.
Nanomedicine (Lond)
. 2012 Oct;
8(5):687-98.
PMID: 23075285
Aim: Two unexplored aspects for irinotecan and cisplatin (I&C) combination chemotherapy are: actively targeting both drugs to a specific diseased cell type, and delivering both drugs on the same vehicle...
13.
Alexis F, Pridgen E, Langer R, Farokhzad O
Handb Exp Pharmacol
. 2010 Mar;
(197):55-86.
PMID: 20217526
Nanoparticles as drug delivery systems enable unique approaches for cancer treatment. Over the last two decades, a large number of nanoparticle delivery systems have been developed for cancer therapy, including...
14.
Pridgen E, Langer R, Farokhzad O
Nanomedicine (Lond)
. 2007 Nov;
2(5):669-80.
PMID: 17976029
Nanotechnology has the potential to impact the treatment of cancer significantly. This review will explore how this potential is beginning to be realized through the design of polymeric nanoparticle delivery...
15.
Kauffman K, Pridgen E, Doyle 3rd F, Dhurjati P, Robinson A
Biotechnol Prog
. 2002 Oct;
18(5):942-50.
PMID: 12363344
Cells are inherently robust to environmental perturbations and have evolved to recover readily from short-term exposure to heat, pH changes, and nutrient deprivation during times of stress. The stress of...